A nurse administers Cervidil vaginally to a client. The nurse is ...

[eruditmonkey@yahoo.com]

A nurse administers Cervidil vaginally to a client. The nurse is aware of what potential hazard related to this drug?
 
  a. Hyperstimulation of the uterus
  b. Increased risk of peripartum infection
  c. Maternal hypotension
  d. Increased incidence of cesarean section

Question 2

While evaluating an external monitor tracing of a woman in active labor whose labor is being induced, the nurse notes that the fetal heart rate (FHR) begins to decelerate at the onset of several contractions and returns to baseline before each
 
  contraction ends. The nurse should: a. Change the woman's position.
  b. Discontinue the oxytocin infusion.
  c. Insert an internal monitor.
  d. Document the finding in the patient's record.

[Jayson]

Answer to Question 1

A
Cervidil is a cervical ripening agent, so hyperstimulation of the uterus can occur. Cervidil contains 10 mg of PGE2 that is released at approximately 0.3 mg per hour over 12 hours.
The insert is placed transversely in the posterior fornix of the vagina, and the client is kept supine for 2 hours but then may ambulate. One benefit of Cervidil is that the insert may be
removed if hyperstimulation (tachysystole) or active labor begins.

Answer to Question 2

D

Feedback
A The FHR indicates early decelerations, which are not an ominous sign and do not require any intervention. The nurse should simply document these findings.
B The presence of early decelerations is not an ominous sign and does not require any intervention.
C The presence of early decelerations is not an ominous sign and does not require any intervention.
D The FHR indicates early decelerations, which are not an ominous sign and do not require any intervention. The nurse should simply document these findings.

[eruditmonkey@yahoo.com]

Thanks for the timely response, appreciate it

[raili21]

YES! Correct, THANKS for helping me on my review